The Canadian Bioceutical Corporation Announces Name Change to MPX Bioceutical Corporation
November 02, 2017 18:54 ET
|
The Canadian Bioceutical Corporation
Election of Board of DirectorsAppoint Deloitte LLP as AuditorAppointment of OfficersIssuance of Stock OptionsEntering into Executive Services Agreement with Canadian Capital, LLC TORONTO, Nov. 02,...
BCC Provides Update on Health Canada Licensed Producer Application and Owen Sound Facility Build Out
October 26, 2017 07:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced it has completed preparatory construction work and...
BCC Announces Initial US$10 Million Drawdown on Credit Facility
October 24, 2017 18:20 ET
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 24, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that it made an initial drawdown of US$10 million under...
BCC Announces Annual Meeting Details
October 13, 2017 10:30 ET
|
The Canadian Bioceutical Corporation
Refresh Board of Directors Appoint Deloitte LLP as Auditors Name Change to MPX Bioceutical Corporation TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the...
BCC Signs Definitive Agreement to Expand Into Second Adult Use Market
October 13, 2017 07:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that, the Company, through its wholly-owned U.S....
BCC Reports Q1 Fiscal 2018 Results
September 28, 2017 21:35 ET
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 28, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) reported its financial results for the first quarter of fiscal 2018,...
BCC Provides Bi-Weekly Update on Status of Management Cease Trade Order
September 21, 2017 11:08 ET
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 21, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) further to missing the July 31, 2017 deadline for filing its audited...
BCC Reports Q4 and Fiscal 2017 Results
September 08, 2017 07:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 08, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today reported its financial results for the fourth quarter and full...
BCC Provides Bi-Weekly Update on Status of Management Cease Trade Order
September 07, 2017 23:00 ET
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) further to missing the July 31, 2017 deadline for filing its audited...
BCC Provides Bi-Weekly Update on Status of Management Cease Trade Order
August 23, 2017 23:20 ET
|
The Canadian Bioceutical Corporation
TORONTO, Aug. 23, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) further to missing the July 31, 2017 deadline for filing its audited...